Insulet (PODD) Tops Q3 EPS by 34c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Insulet (PODD) shares jump after raising full-year revenue growth guidance
November 3, 2023 8:34 AM EDTInsulet (NASDAQ: PODD) shares jumped more than 9% Friday, boosted by the company's latest earnings release, which topped consensus expectations.
The medical device company reported Q3 EPS of $0.74, $0.34 better than the analyst estimate of $0.40, while revenue for the quarter came in at $432.7 million, up 27%... More
